← Back to Search

Behavioral Intervention

dCBI for Inflammatory Bowel Disease

Waitlist Available
Led By Sandra Kim, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test a modified version of RxWell, which will include chronic disease management and transition readiness, to see if it is effective for patients ages 16-25.

Eligible Conditions
  • Inflammatory Bowel Disease
  • Mental Health Issue


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety severity over time
Mental Depression
Secondary outcome measures
Change in Transition Readiness to Adult Care

Trial Design

1Treatment groups
Experimental Treatment
Group I: Digital Cognitive Behavioral Intervention (DCBI)Experimental Treatment1 Intervention
The dCBI, RxWell, is a trans cognitive behavioral therapy (CBT) mobile app product addressing depression and anxiety that was developed based on standard CBT techniques.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,729 Previous Clinical Trials
16,307,483 Total Patients Enrolled
Sandra Kim, MDPrincipal InvestigatorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research program have an age limit?

"The age window for participants in this experiment is 16 to 25 years old."

Answered by AI

Who meets the requirements to be a part of this research project?

"This clinical study is looking for 50 young patients that suffer from inflammatory bowel disease. Eligibility criteria include being between 16-25 years old, being treated at the UPMC Children's Hospital of Pittsburgh, speaking English, having a smartphone, and receiving a PHQ-4 score ≥ 5 and/or TRAQ score ≥ 60."

Answered by AI

How many people are allowed to take part in this research project?

"That is correct. The information available on clinicaltrials.gov indicates that this trial has an open recruitment status. This study was first advertised on 7/30/2022 and received its most recent update on 8/9/2022. There is a total need for 50 individuals spread out over the course of 1 site."

Answered by AI

Can people still sign up to participate in this research?

"This clinical trial is currently looking for participants, with the first posting on July 30th, 2020 and the most recent update being August 9th, 2020."

Answered by AI
~3 spots leftby May 2025